Pulmonx Corporation
LUNGMedical Devices
$3.01−5.06%As of Oct 30vs prior close
- Market cap
- $126.9M
- P/E (TTM)
- –
- From 52W high
- −5.06%
- EPS (LTM)
- -$1.16
- Revenue (LTM)
- $87.4M
- Net margin
- -55.03%
- Dividend yield
- 0.00%
Nomior Score
30
Steady ProfileSpeculativeBottom 16% of the scored universe
Growth53
Quality32
Value37
Momentum42
Resilience33
Growth
+24.06%revenue a year over 7 fiscal years
YE18 $20MLTM $87.4M
Connections
Revenue to profitQ3 YE26
The operating loss was 33% of revenue, narrower by 34 pts on a year.
Who owns it
1fund